{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T07:16:53Z","timestamp":1780384613681,"version":"3.54.1"},"reference-count":108,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.lpm.2023.104173","type":"journal-article","created":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T20:28:44Z","timestamp":1694291324000},"page":"104173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Lymphangioleiomyomatosis"],"prefix":"10.1016","volume":"52","author":[{"given":"Davide","family":"Elia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Cassandro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Caminati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Luisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8629-7391","authenticated-orcid":false,"given":"Sergio","family":"Harari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2023.104173_bib0001","unstructured":"Fletcher C.D., Unni K.K. Epstein J. et al. Pathology and Genetics of Tumours of soft tissue and bone, 2002 WHO IARC."},{"key":"10.1016\/j.lpm.2023.104173_bib0002","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0163-2019","article-title":"Ultra-rare cystic disease","volume":"29","author":"Elia","year":"2020","journal-title":"Eur Respir Rev"},{"issue":"12","key":"10.1016\/j.lpm.2023.104173_bib0003","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1164\/rccm.201411-2094CI","article-title":"Diffuse cystic lung disease. Part I","volume":"191","author":"Gupta","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"145","key":"10.1016\/j.lpm.2023.104173_bib0004","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0042-2017","article-title":"New insights in lymphangioleiomyomatosis and pulmonary Langerhans cell histiocytosis","volume":"26","author":"Torre","year":"2017","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.lpm.2023.104173_bib0005","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/S2213-2600(21)00228-9","article-title":"Lymphangioleiomyomatosis: pathogenesis, clinical features, diagnosis and management","volume":"9","author":"McCarthy","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.lpm.2023.104173_bib0006","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJMoa063564","article-title":"Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis","volume":"358","author":"Bissler","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2023.104173_bib0007","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1056\/NEJMc072500","article-title":"Sirolimus therapy in tuberous sclerosis or sporadic lymphanfioleiomyomatosis","volume":"358","author":"Davies","year":"2008","journal-title":"N Eng J Med"},{"key":"10.1016\/j.lpm.2023.104173_bib0008","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1056\/NEJMoa1100391","article-title":"Efficacy and safety of sirolimus in lymphangioleiomyomatosis","volume":"364","author":"McCormack","year":"2011","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.lpm.2023.104173_bib0009","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1183\/09031936.00210714","article-title":"Everolimus for the treatment of lymphangioleiomyomatosis: a phase II study","volume":"46","author":"Goldberg","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.lpm.2023.104173_bib0010","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.crad.2011.02.009","article-title":"Prokop M Radiological evidence of lymphangioleiomyomatosis in female and male patients with tuberous sclerosis complex","volume":"66","author":"Adriansen","year":"2011","journal-title":"Clin Radiol"},{"issue":"2 Pt 1","key":"10.1016\/j.lpm.2023.104173_bib0011","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1164\/ajrccm.162.2.9911006","article-title":"Pulmonary lymphangioleiomyomatosis in a man","volume":"162","author":"Aubry","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.lpm.2023.104173_bib0012","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1164\/rccm.200610-1408CR","article-title":"Pulmonary lymphangioleiomyomatosis in a karyotypically normal man without tuberous sclerosis complex","volume":"176","author":"Schiavina","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.lpm.2023.104173_bib0013","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1164\/ajrccm.164.4.2101154","article-title":"Prevalence and clinical characteristics of lymphangioleiomyomatosis (LAM) in patients with tuberous sclerosis complex","volume":"164","author":"Moss","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.lpm.2023.104173_bib0014","doi-asserted-by":"crossref","first-page":"591","DOI":"10.4065\/75.6.591","article-title":"Ryu JH High frequency of pulmonary lymphangioleiomyomatosis in women with tuberous sclerosis complex","volume":"75","author":"Costello","year":"2000","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"10.1016\/j.lpm.2023.104173_bib0015","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1164\/rccm.200409-1298OC","article-title":"The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrolment","volume":"173","author":"Ryu","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.lpm.2023.104173_bib0016","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/S1097-2765(03)00220-X","article-title":"Insulin activation of Rheb, a mediator of mTOR\/S6K\/4E-BP signaling, is inhibited by TSC1 and 2","volume":"11","author":"Garami","year":"2003","journal-title":"Mol Cell"},{"issue":"6","key":"10.1016\/j.lpm.2023.104173_bib0017","first-page":"559","article-title":"Rheb is an essential regulator of S6K in controlling cell growth in Drosophila Nat","volume":"5","author":"Stocker","year":"2003","journal-title":"Cell Biol"},{"issue":"4","key":"10.1016\/j.lpm.2023.104173_bib0018","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.molcel.2012.06.009","article-title":"TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1","volume":"47","author":"Dibble","year":"2012","journal-title":"Mol Cell"},{"key":"10.1016\/j.lpm.2023.104173_bib0019","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1038\/onc.2014.164","article-title":"Tee AR. mTORC1 drives H1F-1\u03b1 and VEGF-A signalling via multiple mechanisms involving 4E-BP1,S6K1 and STAT3","volume":"34","author":"Dodd","year":"2015","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.lpm.2023.104173_bib0020","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ccell.2017.09.013","article-title":"mTORC1 Couples Nucleotide Synthesis to Nucleotide Demand Resulting in a Targetable Metabolic Vulnerability","volume":"32","author":"Valvezan","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.lpm.2023.104173_bib0021","doi-asserted-by":"crossref","first-page":"8621","DOI":"10.1074\/jbc.M109.092353","article-title":"Rheb GTPase controls aptosis by regulating interaction of FKBP38 with Bcl-2 and Bcl-XL","volume":"285","author":"Ma","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.lpm.2023.104173_bib0022","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1038\/s41467-020-15156-5","article-title":"Blenis J Rap1-GTPases control mTORC1 activity by coordinating lysome organization with amino acid availability","volume":"11","author":"Mutvei","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.lpm.2023.104173_bib0023","doi-asserted-by":"crossref","unstructured":"Jacinto E., Facchinetti V., Liu D., Soto N., Wei S., Jung S.Y. et al. SIN1\/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity Cell 2006 Oct 6;127(1):125\u201337.","DOI":"10.1016\/j.cell.2006.08.033"},{"issue":"14","key":"10.1016\/j.lpm.2023.104173_bib0024","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.cub.2004.06.054","article-title":"Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton","volume":"14","author":"Sarbassow","year":"2004","journal-title":"Curr Biol"},{"issue":"12","key":"10.1016\/j.lpm.2023.104173_bib0025","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1128\/MCB.01061-10","article-title":"mTORC2 is required for proliferation and survival of TSC2-null cells","volume":"31","author":"Goncharova","year":"2011","journal-title":"Mol Cell Biol"},{"issue":"6","key":"10.1016\/j.lpm.2023.104173_bib0026","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1165\/rcmb.2018-0123OC","article-title":"Rue R et al. Immune Checkpoint Ligand PD-L1 Is Upregulated in Pulmonary Lymphangioleiomyomatosis Am","volume":"59","author":"Maisel","year":"2018","journal-title":"J Respir Cell Mol Biol"},{"issue":"8","key":"10.1016\/j.lpm.2023.104173_bib0027","doi-asserted-by":"crossref","first-page":"e98674","DOI":"10.1172\/jci.insight.98674","article-title":"TSC2-deficient tumors have evidence of T cell exhaustion and respond to anti-PD-1\/anti-CTLA-4 immunotherapy","volume":"3","author":"Liu","year":"2018","journal-title":"JCI Insight"},{"issue":"16","key":"10.1016\/j.lpm.2023.104173_bib0028","doi-asserted-by":"crossref","first-page":"e87270","DOI":"10.1172\/jci.insight.87270","article-title":"NK cell activating receptor ligand expression in lymphangioleiomyomatosis is associated with lung function decline","volume":"1","author":"Osterburg","year":"2016","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.lpm.2023.104173_bib0029","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1053\/hupa.2003.50","article-title":"Recurrence of lymphangioleiomyomatosis after single lung transplantation: new insights into pathogenesis","volume":"34","author":"Bittmann","year":"2003","journal-title":"Hum Pathol"},{"issue":"7","key":"10.1016\/j.lpm.2023.104173_bib0030","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1164\/rccm.200208-969OC","article-title":"Recurrent lymphangiomyomatosis after transplantation: genetic analyses reveal a metastatic mechanism","volume":"167","author":"Karbowniczek","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.lpm.2023.104173_bib0031","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1378\/chest.117.1.25","article-title":"Henske EP Frequent estrogen and progesterone receptor immunoreactivity in renal angiomyolipomas from women with pulmonary lymphangioleiomyomatosis","volume":"117","author":"Logginidou","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.lpm.2023.104173_bib0032","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00428-014-1559-9","article-title":"In pulmonary lymphangioleiomyomatosis expression of progesterone receptor is frequently higher than that of estrogen receptor","volume":"464","author":"Gao","year":"2014","journal-title":"Virchows Arch"},{"key":"10.1016\/j.lpm.2023.104173_bib0033","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1164\/ajrccm.160.2.9901027","article-title":"Decline in lung function in lymphangioleiomyomatosis: relation to menopause and progesterone treatment","volume":"160","author":"Johnson","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.lpm.2023.104173_bib0034","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1136\/thoraxjnl-2020-214987","article-title":"Pregnancy in lymphangioleiomyomatosis: clinical and lung function outcomes in two national cohorts","volume":"75","author":"Taveira-DaSilva","year":"2020","journal-title":"Thorax"},{"key":"10.1016\/j.lpm.2023.104173_bib0035","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1378\/chest.91.5.782","article-title":"Exacerbation of pulmonary lymphangioleiomyomatosis by exogenous estrogens","volume":"91","author":"Shen","year":"1987","journal-title":"Chest"},{"key":"10.1016\/j.lpm.2023.104173_bib0036","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.rmed.2008.11.007","article-title":"Pregnancy experiences among women with lymphangioleiomyomatosis","volume":"103","author":"Cohen","year":"2009","journal-title":"Respir Med"},{"issue":"1","key":"10.1016\/j.lpm.2023.104173_bib0037","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1165\/rcmb.2012-0476OC","article-title":"Faslodex inhibits estradiol-induced extracellular matrix dynamics and lung metastasis in a model of lymphangioleiomyomatosis","volume":"49","author":"Li","year":"2013","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"6","key":"10.1016\/j.lpm.2023.104173_bib0038","doi-asserted-by":"crossref","first-page":"e38589","DOI":"10.1371\/journal.pone.0038589","article-title":"Real-time monitoring of tumorigenesis, dissemination, & drug response in a preclinical model of lymphangioleiomyomatosis\/tuberous sclerosis complex","volume":"7","author":"Liu","year":"2012","journal-title":"PLoS ONE"},{"issue":"8","key":"10.1016\/j.lpm.2023.104173_bib0039","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1073\/pnas.0810790106","article-title":"Astrinidis A et al. Estrogen promotes the survival and pulmonary metastasis of tuberin-null cells","volume":"106","author":"Yu","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.lpm.2023.104173_bib0040","doi-asserted-by":"crossref","first-page":"14960","DOI":"10.1073\/pnas.1309110110","article-title":"Integration of mTOR and estrogen-ERK2 signaling in lymphangioleiomyomatosis pathogenesis","volume":"110","author":"Gu","year":"2013","journal-title":"Proc Natl Acad Sci USA."},{"issue":"5","key":"10.1016\/j.lpm.2023.104173_bib0041","doi-asserted-by":"crossref","first-page":"e1231","DOI":"10.1038\/cddis.2014.204","article-title":"Estradiol promotes pentose phosphate pathway addiction and cell survival via reactivation of Akt in mTORC1 hyperactive cells","volume":"5","author":"Sun","year":"2014","journal-title":"Cell Death Dis"},{"issue":"6","key":"10.1016\/j.lpm.2023.104173_bib0042","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1513\/AnnalsATS.201610-824OC","article-title":"A phase II clinical trial of an aromatase inhibitor for postmenopausal women with lymphangioleiomyomatosis","volume":"14","author":"Lu","year":"2017","journal-title":"Ann Am Thorac Soc"},{"issue":"2","key":"10.1016\/j.lpm.2023.104173_bib0043","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1378\/chest.07-2277","article-title":"Effect of a gonadotrophin-releasing hormone analogue on lung function in lymphangioleiomyomatosis","volume":"133","author":"Harari","year":"2008","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.lpm.2023.104173_bib0044","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1378\/chest.123.2.623","article-title":"Sahn SA Chylothorax in lymphangioleiomyomatosis","volume":"123","author":"Ryu","year":"2003","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.lpm.2023.104173_bib0045","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1378\/chest.129.5.1274","article-title":"Management of pneumothorax in lymphangioleiomyomatosis: effects on recurrence and lung transplantation complications","volume":"129","author":"Almoosa","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.lpm.2023.104173_bib0046","doi-asserted-by":"crossref","first-page":"034","DOI":"10.1183\/09059180.00011010","article-title":"Lymphangioleiomyomatosis: what do we know and what are we looking for?","volume":"20","author":"Harari","year":"2011","journal-title":"Eur Respiratory Rev"},{"issue":"4","key":"10.1016\/j.lpm.2023.104173_bib0047","doi-asserted-by":"crossref","first-page":"982","DOI":"10.2214\/AJR.10.4185","article-title":"Imaging Features of Lymphangioleiomyomatosis: diagnostic Pitfalls AJR","author":"Avila","year":"2011","journal-title":"Am J Roentgenol"},{"issue":"1","key":"10.1016\/j.lpm.2023.104173_bib0048","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1183\/09031936.00076209","article-title":"European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis","volume":"35","author":"Johnson","year":"2010","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.lpm.2023.104173_bib0049","first-page":"147","article-title":"Lymphangioleiomyomatosis: abdominopelvic","volume":"216","author":"Avila","year":"2000","journal-title":"CT US Find Radiol"},{"issue":"1","key":"10.1016\/j.lpm.2023.104173_bib0050","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1148\/radiographics.17.1.9017804","article-title":"Unusual fat-containing tumors of the kidney: a diagnostic dilemma","volume":"17","author":"H\u00e9l\u00e9non","year":"1997","journal-title":"Radiographics"},{"issue":"6","key":"10.1016\/j.lpm.2023.104173_bib0051","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1164\/rccm.201607-1384ST","article-title":"Official American thoracic society\/Japanese respiratory society clinical practice guidelines: lymphangioleiomyomatosis diagnosis and management","volume":"194","author":"McCormack","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.lpm.2023.104173_bib0052","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.2353\/ajpath.2009.080830","article-title":"Vascular endothelial growth factors C and D induces proliferation of lymphangioleiomyomatosis cells through autocrine crosstalk with endothelium","volume":"175","author":"Issaka","year":"2009","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1016\/j.lpm.2023.104173_bib0053","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1056\/NEJMc0707517","article-title":"Diagnostic potential of serum VEGF-D for lymphangioleiomyomatosis","volume":"358","author":"Young","year":"2008","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.lpm.2023.104173_bib0054","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1378\/chest.10-0573","article-title":"Serum vascular endothelial growth factor-D prospectively distinguishes lymphangioleiomyomatosis from other diseases","volume":"138","author":"Young","year":"2010","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.lpm.2023.104173_bib0055","doi-asserted-by":"crossref","first-page":"533","DOI":"10.20452\/pamw.1927","article-title":"Role of serum vascular endothelial growth factor D in discrimination of patients with polycystic lung diseases","volume":"123","author":"Radzikowska","year":"2013","journal-title":"Pol Arch Med Wewn"},{"issue":"6","key":"10.1016\/j.lpm.2023.104173_bib0056","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S2213-2600(13)70090-0","article-title":"Serum VEGF-D a concentration as a biomarker of lymphangioleiomyomatosis severity and treatment response: a prospective analysis of the Multicenter International Lymphangioleiomyomatosis Efficacy of Sirolimus (MILES) trial","volume":"1","author":"Young","year":"2013","journal-title":"Lancet Respir Med"},{"issue":"50","key":"10.1016\/j.lpm.2023.104173_bib0057","doi-asserted-by":"crossref","first-page":"17462","DOI":"10.1073\/pnas.0407971101","article-title":"Molecular and genetic analysis of disseminated neoplastic cells in lymphangioleiomyomatosis","volume":"101","author":"Crooks","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.lpm.2023.104173_bib0058","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1378\/chest.13-1071","article-title":"Sirolimus decreases circulating lymphangioleiomyomatosis cells in patients with ymphangioleiomyomatosis","volume":"145","author":"Cai","year":"2014","journal-title":"Chest"},{"issue":"7","key":"10.1016\/j.lpm.2023.104173_bib0059","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1164\/rccm.200208-969OC","article-title":"Recurrent lymphangiomyomatosis after transplantation: genetic analyses reveal a metastatic mechanism","volume":"167","author":"Karbowniczek","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.lpm.2023.104173_bib0060","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.chest.2022.02.032","article-title":"Pulmonary langerhans cell histiocytosis and lymphangioleiomyomatosis have circulating cells with loss of heterozygosity of the TSC2","volume":"162","author":"Elia","year":"2022","journal-title":"Gene Chest"},{"issue":"9","key":"10.1016\/j.lpm.2023.104173_bib0061","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0046-8177(97)90061-7","article-title":"Immunohistochemical study of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in pulmonary lymphangioleiomyomatosis (LAM)","volume":"28","author":"Hayashi","year":"1997","journal-title":"Hum Pathol"},{"issue":"Suppl 1","key":"10.1016\/j.lpm.2023.104173_bib0062","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/j.rmed.2010.03.017","article-title":"Lymphangioleiomyomatosis (LAM): molecular insights lead to targeted therapies","volume":"104","author":"Glasgow","year":"2010","journal-title":"Respir Med"},{"issue":"1","key":"10.1016\/j.lpm.2023.104173_bib0063","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.rmed.2008.07.017","article-title":"Matrix metalloproteinases in blood from patients with LAM","volume":"103","author":"Odajima","year":"2009","journal-title":"Respir Med"},{"key":"10.1016\/j.lpm.2023.104173_bib0064","article-title":"Exploring the Role of Matrix Metalloproteinases as Biomarkers in Sporadic Lymphangioleiomyomatosis and Tuberous Sclerosis Complex","volume":"8","author":"Terraneo","year":"2021","journal-title":"A Pilot Study Front Med (Lausanne)"},{"issue":"6","key":"10.1016\/j.lpm.2023.104173_bib0065","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s00408-014-9641-2","article-title":"Evaluation of the extent of pulmonary cysts and their association with functional variables and serum markers in lymphangioleiomyomatosis (LAM)","volume":"192","author":"Baldi","year":"2014","journal-title":"Lung"},{"issue":"3","key":"10.1016\/j.lpm.2023.104173_bib0066","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/resp.13190","article-title":"Efficacy and safety of transbronchial lung biopsy for the diagnosis of lymphangioleiomyomatosis: a report of 24 cases","volume":"23","author":"Koba","year":"2018","journal-title":"Respirology"},{"issue":"10","key":"10.1016\/j.lpm.2023.104173_bib0067","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1164\/rccm.201709-1965ST","article-title":"Lymphangioleiomyomatosis diagnosis and management: high-resolution chest computed tomography, transbronchial lung biopsy, and pleural disease management. An official American thoracic society\/Japanese respiratory society clinical practice guideline","volume":"196","author":"Gupta","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.1016\/j.lpm.2023.104173_bib0068","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.rmed.2012.06.012","article-title":"Bronchoscopic diagnosis of Langerhans cell histiocytosis and lymphangioleiomyomatosis","volume":"106","author":"Harari","year":"2012","journal-title":"Respir Med"},{"issue":"12","key":"10.1016\/j.lpm.2023.104173_bib0069","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1369\/jhc.4A6438.2004","article-title":"Combined smooth muscle and melanocytic differentiation in lymphangioleiomyomatosis","volume":"52","author":"Zhe","year":"2004","journal-title":"J Histochem Cytochem"},{"issue":"1","key":"10.1016\/j.lpm.2023.104173_bib0070","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1378\/chest.85.1.96","article-title":"Oshima CT Steroid receptors in pulmonary lymphangiomyomatosis","volume":"85","author":"Brentani","year":"1984","journal-title":"Chest"},{"issue":"3 Pt 1","key":"10.1016\/j.lpm.2023.104173_bib0071","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1164\/ajrccm.161.3.9904009","article-title":"Ferrans VJ Downregulation of estrogen and progesterone receptors in the abnormal smooth muscle cells in pulmonary lymphangioleiomyomatosis following therapy. An immunohistochemical study","volume":"161","author":"Matsui","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1016\/j.lpm.2023.104173_bib0072","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1164\/rccm.200206-593OC","article-title":"Maximal oxygen uptake and severity of disease in lymphangioleiomyomatosis","volume":"168","author":"Taveira-DaSilva","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.lpm.2023.104173_bib0073","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1378\/chest.09-0624","article-title":"Reversible airflow obstruction in lymphangioleiomyomatosis","volume":"136","author":"Taveira-DaSilva","year":"2009","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.lpm.2023.104173_bib0074","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1378\/chest.125.1.135","article-title":"Diffuse cystic lung diseases: correlation between radiologic and functional status","volume":"125","author":"Paciocco","year":"2004","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.lpm.2023.104173_bib0075","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1186\/s12890-022-02123-7","article-title":"Computer grading of lung disease severity in patients with lymphangioleiomyomatosis referred for transplantation","volume":"22","author":"Taveira-DaSilva","year":"2022","journal-title":"BMC Pulm Med"},{"issue":"2","key":"10.1016\/j.lpm.2023.104173_bib0076","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.chest.2018.06.016","article-title":"The NHLBI LAM registry: prognostic physiologic and radiologic biomarkers emerge from a 15-year prospective longitudinal","volume":"155","author":"Gupta","year":"2019","journal-title":"Analysis Chest"},{"issue":"6","key":"10.1016\/j.lpm.2023.104173_bib0077","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1164\/ajrccm.164.6.2102125","article-title":"Reversible airflow obstruction, proliferation of abnormal smooth muscle cells, and impairment of gas exchange as predictors of outcome in lymphangioleiomyomatosis","volume":"164","author":"Taveira-DaSilva","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.lpm.2023.104173_bib0078","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.04270-2020","article-title":"Methacholine reactivity in lymphangioleiomyomatosis is inversely related to FEV1 and VEGF-D","volume":"57","author":"Cassandro","year":"2021","journal-title":"Eur Respir J"},{"issue":"17","key":"10.1016\/j.lpm.2023.104173_bib0079","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1056\/NEJMoa1100391","article-title":"Efficacy and safety of sirolimus in lymphangioleiomyomatosis","volume":"364","author":"McCormack","year":"2011","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.lpm.2023.104173_bib0080","doi-asserted-by":"crossref","first-page":"797","DOI":"10.7326\/0003-4819-154-12-201106210-00007","article-title":"Changes in lung function and chylous effusions in patients with lymphangioleiomyomatosis treated with sirolimus","volume":"154","author":"Taveira-DaSilva","year":"2011","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.lpm.2023.104173_bib0081","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1016\/j.chest.2016.02.654","article-title":"Sirolimus therapy for patients with lymphangioleiomyomatosis leads to loss of chylous ascites and circulating LAM","volume":"150","author":"Harari","year":"2016","journal-title":"Cells Chest"},{"issue":"4","key":"10.1016\/j.lpm.2023.104173_bib0082","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1136\/thoraxjnl-2017-210872","article-title":"Lung function response and side effects to rapamycin for lymphangioleiomyomatosis: a prospective national cohort study","volume":"73","author":"Bee","year":"2018","journal-title":"Thorax"},{"issue":"8","key":"10.1016\/j.lpm.2023.104173_bib0083","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0180939","article-title":"Everolimus long-term use in patients with tuberous sclerosis complex: four-year update of the EXIST-2 study","volume":"12","author":"Bissler","year":"2017","journal-title":"PLoS ONE"},{"issue":"24","key":"10.1016\/j.lpm.2023.104173_bib0084","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1056\/NEJMc053410","article-title":"Doxycycline treatment for lymphangioleiomyomatosis with urinary monitoring for MMPs","volume":"354","author":"Moses","year":"2006","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.lpm.2023.104173_bib0085","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1183\/09031936.00167413","article-title":"A 2-year randomised placebo-controlled trial of doxycycline for lymphangioleiomyomatosis","volume":"43","author":"Chang","year":"2014","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.lpm.2023.104173_bib0086","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1183\/09031936.00008114","article-title":"Doxycycline in lymphangioleiomyomatosis: not all questions are answered","volume":"43","author":"Baldi","year":"2014","journal-title":"Eur Respir J"},{"issue":"30","key":"10.1016\/j.lpm.2023.104173_bib0087","doi-asserted-by":"crossref","first-page":"12455","DOI":"10.1073\/pnas.1104361108","article-title":"Tumorigenesis in tuberous sclerosis complex is autophagy and p62\/sequestosome 1 (SQSTM1)-dependent","volume":"108","author":"Parkhitko","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.lpm.2023.104173_bib0088","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.chest.2017.01.033","article-title":"Sirolimus and autophagy inhibition in lymphangioleiomyomatosis: results of a phase I clinical","volume":"151","author":"El-Chemaly","year":"2017","journal-title":"Trial Chest"},{"key":"10.1016\/j.lpm.2023.104173_bib0089","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2020.105898","article-title":"A phase II clinical trial of the Safety Of Simvastatin (SOS) in patients with pulmonary lymphangioleiomyomatosis and with tuberous sclerosis complex","volume":"163","author":"Krymskaya","year":"2020","journal-title":"Respir Med"},{"issue":"5","key":"10.1016\/j.lpm.2023.104173_bib0090","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02370-2019","article-title":"Lamattina AM Celecoxib in lymphangioleiomyomatosis: results of a phase I clinical trial","volume":"55","author":"El-Chemaly","year":"2020","journal-title":"Eur Respir J"},{"issue":"9","key":"10.1016\/j.lpm.2023.104173_bib0091","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0163637","article-title":"A total pleural covering for lymphangioleiomyomatosis prevents pneumothorax recurrence","volume":"11","author":"Kurihara","year":"2016","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.lpm.2023.104173_bib0092","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s13023-018-0915-2","article-title":"Efficacy of sirolimus for the prevention of recurrent pneumothorax in patients with lymphangioleiomyomatosis: a case series","volume":"13","author":"Zhou","year":"2018","journal-title":"Orphanet J Rare Dis"},{"issue":"8","key":"10.1016\/j.lpm.2023.104173_bib0093","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.echo.2018.02.004","article-title":"Hemodynamic mechanisms of exercise-induced pulmonary hypertension in patients with lymphangioleiomyomatosis: the role of exercise","volume":"31","author":"Sonaglioni","year":"2018","journal-title":"Stress Echocardiography J Am Soc Echocardiogr"},{"issue":"1","key":"10.1016\/j.lpm.2023.104173_bib0094","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13023-017-0626-0","article-title":"Pulmonary hypertension in lymphangioleiomyomatosis: prevalence, severity and the role of carbon monoxide diffusion capacity as a screening method","volume":"12","author":"Freitas","year":"2017","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"10.1016\/j.lpm.2023.104173_bib0095","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1378\/chest.07-1205","article-title":"Pulmonary artery pressure in lymphangioleiomyomatosis: an echocardiographic study","volume":"132","author":"Taveira-DaSilva","year":"2007","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.lpm.2023.104173_bib0096","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00879-2022","article-title":"2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"61","author":"Humbert","year":"2023","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.lpm.2023.104173_bib0097","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1183\/09031936.00093111","article-title":"Pulmonary hypertension in lymphangioleiomyomatosis: characteristics in 20 patients","volume":"40","author":"Cottin","year":"2012","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.lpm.2023.104173_bib0098","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s11684-018-0634-z","article-title":"Clinical characteristics in lymphangioleiomyomatosis-related pulmonary hypertension: an observation on 50 patients","volume":"13","author":"Wu","year":"2019","journal-title":"Front Med"},{"issue":"11","key":"10.1016\/j.lpm.2023.104173_bib0099","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.healun.2021.07.005","article-title":"Consensus document for the selection of lung transplant candidates: an update from the International Society for Heart and","volume":"40","author":"Leard","year":"2021","journal-title":"Lung Transplantation J Heart Lung Transplant"},{"issue":"10","key":"10.1016\/j.lpm.2023.104173_bib0100","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1159\/000516330","article-title":"Improving survival in lymphangioleio-myomatosis: a 16-year observational study in a large cohort of patients","volume":"100","author":"Harari","year":"2021","journal-title":"Respiration"},{"issue":"1","key":"10.1016\/j.lpm.2023.104173_bib0101","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/s13023-018-0964-6","article-title":"Air travel and incidence of pneumothorax in lymphangioleiomyomatosis","volume":"13","author":"Gonano","year":"2018","journal-title":"Orphanet J Rare Dis"},{"issue":"10","key":"10.1016\/j.lpm.2023.104173_bib0102","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1136\/thoraxjnl-2020-214987","article-title":"Pregnancy in lymphangioleiomyomatosis: clinical and lung function outcomes in two national cohorts","volume":"75","author":"Taveira-DaSilva","year":"2020","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.lpm.2023.104173_bib0103","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.rmed.2008.11.007","article-title":"Johnson SR Pregnancy experiences among women with lymphangioleiomyomatosis","volume":"103","author":"Cohen","year":"2009","journal-title":"Respir Med"},{"issue":"2","key":"10.1016\/j.lpm.2023.104173_bib0104","doi-asserted-by":"crossref","first-page":"19","DOI":"10.22551\/2021.31.0802.10180","article-title":"Maternal sirolimus therapy and fetal growth restriction","volume":"8","author":"Tshering","year":"2021","journal-title":"Arch Clin Cases"},{"issue":"4","key":"10.1016\/j.lpm.2023.104173_bib0105","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02066-2018","article-title":"Analysis of the MILES cohort reveals determinants of disease progression and treatment response in lymphangioleiomyomatosis","volume":"53","author":"Gupta","year":"2019","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.lpm.2023.104173_bib0106","article-title":"Serum vascular endothelial growth factor-D as a diagnostic and therapeutic biomarker for lymphangioleiomyomatosis","volume":"14","author":"Hirose","year":"2019","journal-title":"PLoS One cha"},{"issue":"1","key":"10.1016\/j.lpm.2023.104173_bib0107","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1465-9921-13-34","article-title":"Clinical utility of diagnostic guidelines and putative biomarkers in lymphangioleiomyomatosis","volume":"13","author":"Chang","year":"2012","journal-title":"Respir Res"},{"issue":"2 Pt 1","key":"10.1016\/j.lpm.2023.104173_bib0108","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1164\/ajrccm.151.2.7842216","article-title":"Pulmonary lymphangioleiomyomatosis: a report of 46 patients including a clinicopathologic study of prognostic factors","volume":"151","author":"Kitaichi","year":"1995","journal-title":"Am J Respir Crit Care Med"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498223000106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498223000106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:09:55Z","timestamp":1760105395000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498223000106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":108,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0755498223000106"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2023.104173","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lymphangioleiomyomatosis","name":"articletitle","label":"Article Title"},{"value":"La Presse M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2023.104173","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104173"}}